NOT KNOWN FACTS ABOUT MBL77

Moreover, several perfectly recognized adverse prognostic markers, including U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their negative outcome in patients addressed with VO. The one component that remained predictive of a shorter development-cost-free survival With this cohort of patients was TP53 aberrations.112 Eventually, the choice